2018 SPEAKERS

 

Mitul Agarwal, GM- Business Development & Licensing, Intas Pharmaceuticals Ltd

Mitul Agarwal at World Biosimilar Congress USA 2018

Anna Aillerie, Former Director, Commercial Biosimilars, Lupin Ltd

Anna Aillerie at World Biosimilar Congress USA 2018

Parastoo Azadi, Technical Director of Analytical Services and Senior Research Scientist, Complex Carbohydrate Research Center

Parastoo Azadi at World Biosimilar Congress USA 2018

Julio Baez, Former Head, Technology, Cipla BioTec

Julio Baez at World Biosimilar Congress USA 2018

Luiz Barberini, External Manufacturing Organization Head, Bayer

Luiz Barberini at World Biosimilar Congress USA 2018

Abdelhamid Cherfaoui, CEO, laboratory Frater -Razes

Abdelhamid Cherfaoui at World Biosimilar Congress USA 2018

Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network

Matt Cooper at World Biosimilar Congress USA 2018

Jennifer Day, Coordinator, Emerging Therapeutics Strategy Program, Kaiser Permanente

Jennifer Day at World Biosimilar Congress USA 2018

Yi Du, Director, Strategic Alliances, Huahai Pharma

Yi Du at World Biosimilar Congress USA 2018

Rajiv Dua, Site & Analytical Technical Services Head, Sun Pharma

Rajiv Dua at World Biosimilar Congress USA 2018

Ronald Dudek, Director, Technology Development and Marketing, Lentigen Corporation

Ronald Dudek at World Biosimilar Congress USA 2018

Tiffany Fletcher, Executive Director of Government Affairs, Biosimilars, Sandoz

Tiffany Fletcher at World Biosimilar Congress USA 2018

Vimal Gandhi, Director, Global Biosimilar Operations and Strategy, AstraZeneca

Vimal Gandhi at World Biosimilar Congress USA 2018

TJ Garrigan, Senior Director, Policy, Association for Accessible Medicines

TJ Garrigan at World Biosimilar Congress USA 2018

Nacer Hedroug, Former Director, QA Ops Injectable Vertical & Tech Transfer, Mylan Inc.

Nacer Hedroug at World Biosimilar Congress USA 2018

Gerry Hoehn, Medical Director, Oncology, Teva Pharmaceuticals U.S.A.

Gerry Hoehn at World Biosimilar Congress USA 2018

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress USA 2018

Brad Jordan, Director, Global Regulatory Affairs and R&D Policy, Amgen

Brad Jordan at World Biosimilar Congress USA 2018

Bryan Kim, Vice President, Business Development, Samsung Bioepis

Bryan Kim at World Biosimilar Congress USA 2018

Cheryl Koehn, President, Arthritis Consumer Experts

Cheryl Koehn at World Biosimilar Congress USA 2018

Chrys Kokino, Head of Global Biologics & Insulins Commercial, Mylan Inc.

Chrys Kokino at World Biosimilar Congress USA 2018

Dinesh Kundu, GM, Strategy, BD & Program Management, Intas Pharmaceuticals Ltd. – Biopharma Division

Dinesh Kundu at World Biosimilar Congress USA 2018

Lawrence LaMotte, Vice President of Public Policy, Immune Deficiency Foundation

Lawrence LaMotte at World Biosimilar Congress USA 2018

Brian Lehman, Strategic Consultant, Pharmacy Professional Affairs, Humana

Brian Lehman at World Biosimilar Congress USA 2018

Bruce Leicher, Senior Vice President, General Counsel, Momenta Pharmaceuticals Inc

Bruce Leicher at World Biosimilar Congress USA 2018

Asif Mahmood, Safety strategy Disease Area Lead, Biosimilars, Pfizer

Asif Mahmood at World Biosimilar Congress USA 2018

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at World Biosimilar Congress USA 2018

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Sarfaraz Niazi at World Biosimilar Congress USA 2018

Diane Retallack, Sr. Director, Upstream Processing and Intellectual Property, Pfenex Inc

Diane Retallack at World Biosimilar Congress USA 2018

Eef Schimmelpennink, Chief Executive Officer, Pfenex Inc

Eef Schimmelpennink at World Biosimilar Congress USA 2018

Bob Shelley, Vice President of Biosimilars Account Management, Pfizer

Bob Shelley at World Biosimilar Congress USA 2018

Andrew Simpson, Scientific Director, Orygen Biotecnologia

Andrew Simpson at World Biosimilar Congress USA 2018

Klemen Spaninger, Director of Project Management, Polpharma Biologics

Klemen Spaninger at World Biosimilar Congress USA 2018

Don Stewart, President and Chief Executive Officer, PlantForm

Don Stewart at World Biosimilar Congress USA 2018

Vijay Tammara, Global Regulatory Head, Biosimilars, Wockhardt Limited

Vijay Tammara at World Biosimilar Congress USA 2018

Boxiong Tang, Senior Director, Teva Pharmaceuticals United State of America

Boxiong Tang at World Biosimilar Congress USA 2018

Vijay Nag Thota, DGM, RA, Product Strategy, Hetero Biopharma

Vijay Nag Thota at World Biosimilar Congress USA 2018

Giulia Vestri, Global Strategic Marketing Project Leader, Menarini

Giulia Vestri at World Biosimilar Congress USA 2018

Vladimir Vexler, EVP, Analytical and Translational Sciences, Coherus Biosciences

Vladimir Vexler at World Biosimilar Congress USA 2018

Anna Rose Welch, Executive Editor, Biosimilar Development

Anna Rose Welch at World Biosimilar Congress USA 2018

Chad Woods, Head of Patient Access, Sandoz

Chad Woods at World Biosimilar Congress USA 2018

Penny Zhu, Senior Investigator I Clinical Pharmacology, Novartis

Penny Zhu at World Biosimilar Congress USA 2018